Byron Caughey - Publications

Affiliations: 
NIH RML 

44 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Aguilar-Calvo P, Malik A, Sandoval DR, Barback C, Orrù CD, Standke HG, Thomas OR, Dwyer CA, Pizzo DP, Bapat J, Soldau K, Ogawa R, Riley MB, Nilsson KPR, Kraus A, ... Caughey B, et al. Neuronal Ndst1 depletion accelerates prion protein clearance and slows neurodegeneration in prion infection. Plos Pathogens. 19: e1011487. PMID 37747931 DOI: 10.1371/journal.ppat.1011487  0.306
2022 Artikis E, Kraus A, Caughey B. Structural biology of ex vivo mammalian prions. The Journal of Biological Chemistry. 102181. PMID 35752366 DOI: 10.1016/j.jbc.2022.102181  0.337
2021 Kraus A, Hoyt F, Schwartz CL, Hansen B, Artikis E, Hughson AG, Raymond GJ, Race B, Baron GS, Caughey B. High-resolution structure and strain comparison of infectious mammalian prions. Molecular Cell. PMID 34433091 DOI: 10.1016/j.molcel.2021.08.011  0.307
2021 Nahass GR, Sun Y, Xu Y, Batchelor M, Reilly M, Benilova I, Kedia N, Spehar K, Sobott F, Sessions RB, Caughey BW, Radford SE, Jat P, Collinge J, Bieschke J. Brazilin Removes Toxic alpha-Synuclein and Seeding Competent Assemblies from Parkinson Brain by Altering Conformational Equilibrium. Journal of Molecular Biology. 166878. PMID 33610557 DOI: 10.1016/j.jmb.2021.166878  0.326
2020 Artikis E, Roy A, Verli H, Cordeiro Y, Caughey B. Accommodation of In-Register N-Linked Glycans on Prion Protein Amyloid Cores. Acs Chemical Neuroscience. PMID 33180459 DOI: 10.1021/acschemneuro.0c00635  0.315
2019 Caughey B, Kraus A. Transmissibility versus Pathogenicity of Self-Propagating Protein Aggregates. Viruses. 11. PMID 31717531 DOI: 10.3390/v11111044  0.309
2019 Metrick MA, do Carmo Ferreira N, Saijo E, Hughson AG, Kraus A, Orrú C, Miller MW, Zanusso G, Ghetti B, Vendruscolo M, Caughey B. Million-fold sensitivity enhancement in proteopathic seed amplification assays for biospecimens by Hofmeister ion comparisons. Proceedings of the National Academy of Sciences of the United States of America. PMID 31641070 DOI: 10.1073/Pnas.1909322116  0.34
2017 Groveman BR, Raymond GJ, Campbell KJ, Race B, Raymond LD, Hughson AG, Orrú CD, Kraus A, Phillips K, Caughey B. Role of the central lysine cluster and scrapie templating in the transmissibility of synthetic prion protein aggregates. Plos Pathogens. 13: e1006623. PMID 28910420 DOI: 10.1371/Journal.Ppat.1006623  0.331
2017 Kraus A, Raymond GJ, Race B, Campbell KJ, Hughson AG, Anson KJ, Raymond LD, Caughey B. PrP P102L and nearby lysine mutations promote spontaneous in vitro formation of transmissible prions. Journal of Virology. PMID 28835493 DOI: 10.1128/Jvi.01276-17  0.394
2017 Wang F, Wang X, Orrú CD, Groveman BR, Surewicz K, Abskharon R, Imamura M, Yokoyama T, Kim YS, Vander Stel KJ, Sinniah K, Priola SA, Surewicz WK, Caughey B, Ma J. Self-propagating, protease-resistant, recombinant prion protein conformers with or without in vivo pathogenicity. Plos Pathogens. 13: e1006491. PMID 28704563 DOI: 10.1371/Journal.Ppat.1006491  0.3
2016 Hughson AG, Race B, Kraus A, Sangaré LR, Robins L, Groveman BR, Saijo E, Phillips K, Contreras L, Dhaliwal V, Manca M, Zanusso G, Terry D, Williams JF, Caughey B. Inactivation of Prions and Amyloid Seeds with Hypochlorous Acid. Plos Pathogens. 12: e1005914. PMID 27685252 DOI: 10.1371/Journal.Ppat.1005914  0.32
2016 Kellock J, Hopping G, Caughey B, Daggett V. Peptides comprised of alternating L- and D- Amino acids inhibit amyloidogenesis in Three Distinct Amyloid Systems independent of sequence. Journal of Molecular Biology. PMID 27012425 DOI: 10.1016/J.Jmb.2016.03.013  0.525
2015 Kraus A, Anson KJ, Raymond LD, Martens C, Groveman BR, Dorward DW, Caughey B. Prion protein prolines 102 and 105 and the surrounding lysine cluster impede amyloid formation. The Journal of Biological Chemistry. PMID 26175152 DOI: 10.1074/Jbc.M115.665844  0.338
2015 Groveman BR, Kraus A, Raymond LD, Dolan MA, Anson KJ, Dorward DW, Caughey B. Charge neutralization of the central lysine cluster in prion protein (PrP) promotes PrP(Sc)-like folding of recombinant PrP amyloids. The Journal of Biological Chemistry. 290: 1119-28. PMID 25416779 DOI: 10.1074/Jbc.M114.619627  0.319
2014 Groveman BR, Dolan MA, Taubner LM, Kraus A, Wickner RB, Caughey B. Parallel in-register intermolecular β-sheet architectures for prion-seeded prion protein (PrP) amyloids Journal of Biological Chemistry. 289: 24129-24142. PMID 25028516 DOI: 10.1074/Jbc.M114.578344  0.407
2014 Hopping G, Kellock J, Barnwal RP, Law P, Bryers J, Varani G, Caughey B, Daggett V. Designed α-sheet peptides inhibit amyloid formation by targeting toxic oligomers. Elife. 3: e01681. PMID 25027691 DOI: 10.7554/Elife.01681  0.539
2014 Vieira TC, Cordeiro Y, Caughey B, Silva JL. Heparin binding confers prion stability and impairs its aggregation. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 28: 2667-76. PMID 24648544 DOI: 10.1096/Fj.13-246777  0.343
2013 Hopping G, Kellock J, Caughey B, Daggett V. Designed Trpzip-3 β-Hairpin Inhibits Amyloid Formation in Two Different Amyloid Systems. Acs Medicinal Chemistry Letters. 4: 824-8. PMID 24900756 DOI: 10.1021/Ml300478W  0.503
2013 Kraus A, Groveman BR, Caughey B. Prions and the potential transmissibility of protein misfolding diseases. Annual Review of Microbiology. 67: 543-64. PMID 23808331 DOI: 10.1146/Annurev-Micro-092412-155735  0.306
2012 Peden AH, McGuire LI, Appleford NE, Mallinson G, Wilham JM, Orrú CD, Caughey B, Ironside JW, Knight RS, Will RG, Green AJ, Head MW. Sensitive and specific detection of sporadic Creutzfeldt-Jakob disease brain prion protein using real-time quaking-induced conversion. The Journal of General Virology. 93: 438-49. PMID 22031526 DOI: 10.1099/vir.0.033365-0  0.316
2011 Smirnovas V, Baron GS, Offerdahl DK, Raymond GJ, Caughey B, Surewicz WK. Structural organization of brain-derived mammalian prions examined by hydrogen-deuterium exchange. Nature Structural & Molecular Biology. 18: 504-6. PMID 21441913 DOI: 10.1038/Nsmb.2035  0.308
2010 Kim JI, Cali I, Surewicz K, Kong Q, Raymond GJ, Atarashi R, Race B, Qing L, Gambetti P, Caughey B, Surewicz WK. Mammalian prions generated from bacterially expressed prion protein in the absence of any mammalian cofactors. The Journal of Biological Chemistry. 285: 14083-7. PMID 20304915 DOI: 10.1074/Jbc.C110.113464  0.321
2009 Smirnovas V, Kim JI, Lu X, Atarashi R, Caughey B, Surewicz WK. Distinct structures of scrapie prion protein (PrPSc)-seeded versus spontaneous recombinant prion protein fibrils revealed by hydrogen/deuterium exchange. The Journal of Biological Chemistry. 284: 24233-41. PMID 19596861 DOI: 10.1074/Jbc.M109.036558  0.358
2009 Caughey B, Baron GS, Chesebro B, Jeffrey M. Getting a grip on prions: oligomers, amyloids, and pathological membrane interactions. Annual Review of Biochemistry. 78: 177-204. PMID 19231987 DOI: 10.1146/Annurev.Biochem.78.082907.145410  0.343
2009 Sim VL, Caughey B. Ultrastructures and strain comparison of under-glycosylated scrapie prion fibrils. Neurobiology of Aging. 30: 2031-42. PMID 18394757 DOI: 10.1016/j.neurobiolaging.2008.02.016  0.306
2007 Atarashi R, Moore RA, Sim VL, Hughson AG, Dorward DW, Onwubiko HA, Priola SA, Caughey B. Ultrasensitive detection of scrapie prion protein using seeded conversion of recombinant prion protein. Nature Methods. 4: 645-50. PMID 17643109 DOI: 10.1038/Nmeth1066  0.305
2006 DeMarco ML, Silveira J, Caughey B, Daggett V. Structural properties of prion protein protofibrils and fibrils: an experimental assessment of atomic models. Biochemistry. 45: 15573-82. PMID 17176078 DOI: 10.1021/Bi0612723  0.462
2005 Silveira JR, Raymond GJ, Hughson AG, Race RE, Sim VL, Hayes SF, Caughey B. The most infectious prion protein particles. Nature. 437: 257-61. PMID 16148934 DOI: 10.1038/nature03989  0.33
2005 Chesebro B, Trifilo M, Race R, Meade-White K, Teng C, LaCasse R, Raymond L, Favara C, Baron G, Priola S, Caughey B, Masliah E, Oldstone M. Anchorless prion protein results in infectious amyloid disease without clinical scrapie. Science (New York, N.Y.). 308: 1435-9. PMID 15933194 DOI: 10.1126/Science.1110837  0.309
2003 Caughey B, Lansbury PT. Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders. Annual Review of Neuroscience. 26: 267-98. PMID 12704221 DOI: 10.1146/Annurev.Neuro.26.010302.081142  0.358
2002 Caughey B, Baron GS. Factors affecting interactions between prion protein isoforms. Biochemical Society Transactions. 30: 565-9. PMID 12196138 DOI: 10.1042/  0.325
2001 Xiong LW, Raymond LD, Hayes SF, Raymond GJ, Caughey B. Conformational change, aggregation and fibril formation induced by detergent treatments of cellular prion protein. Journal of Neurochemistry. 79: 669-78. PMID 11701770 DOI: 10.1046/j.1471-4159.2001.00606.x  0.335
2001 Callahan MA, Xiong L, Caughey B. Reversibility of scrapie-associated prion protein aggregation. The Journal of Biological Chemistry. 276: 28022-8. PMID 11375994 DOI: 10.1074/jbc.M103629200  0.329
2001 Horiuchi M, Baron GS, Xiong LW, Caughey B. Inhibition of interactions and interconversions of prion protein isoforms by peptide fragments from the C-terminal folded domain. The Journal of Biological Chemistry. 276: 15489-97. PMID 11279046 DOI: 10.1074/jbc.M100288200  0.357
2001 Caughey B, Pepys MB, Kelly JW, Ellis RJ, Collinge J, Perutz MF, Masel J. Prion protein interconversions Philosophical Transactions of the Royal Society B: Biological Sciences. 356: 197-202. PMID 11260800 DOI: 10.1098/rstb.2000.0765  0.301
2000 Horiuchi M, Priola SA, Chabry J, Caughey B. Interactions between heterologous forms of prion protein: binding, inhibition of conversion, and species barriers. Proceedings of the National Academy of Sciences of the United States of America. 97: 5836-41. PMID 10811921 DOI: 10.1073/Pnas.110523897  0.301
1999 Horiuchi M, Caughey B. Prion protein interconversions and the transmissible spongiform encephalopathies. Structure (London, England : 1993). 7: R231-40. PMID 10545332 DOI: 10.1016/S0969-2126(00)80049-0  0.301
1998 Caughey WS, Raymond LD, Horiuchi M, Caughey B. Inhibition of protease-resistant prion protein formation by porphyrins and phthalocyanines. Proceedings of the National Academy of Sciences of the United States of America. 95: 12117-22. PMID 9770449 DOI: 10.1073/pnas.95.21.12117  0.314
1998 Weber DJ, McFadden PN, Caughey B. Measurement of altered aspartyl residues in the scrapie associated form of prion protein Biochemical and Biophysical Research Communications. 246: 606-608. PMID 9618258 DOI: 10.1006/Bbrc.1998.8672  0.304
1998 Chabry J, Caughey B, Chesebro B. Specific inhibition of in vitro formation of protease-resistant prion protein by synthetic peptides. The Journal of Biological Chemistry. 273: 13203-7. PMID 9582363 DOI: 10.1074/Jbc.273.21.13203  0.34
1997 DebBurman SK, Raymond GJ, Caughey B, Lindquist S. Chaperone-supervised conversion of prion protein to its protease-resistant form. Proceedings of the National Academy of Sciences of the United States of America. 94: 13938-43. PMID 9391131 DOI: 10.1073/pnas.94.25.13938  0.324
1997 Bessen RA, Raymond GJ, Caughey B. In situ formation of protease-resistant prion protein in transmissible spongiform encephalopathy-infected brain slices. The Journal of Biological Chemistry. 272: 15227-31. PMID 9182546 DOI: 10.1074/jbc.272.24.15227  0.322
1995 Priola SA, Caughey B. Inhibition of scrapie-associated PrP accumulation. Probing the role of glycosaminoglycans in amyloidogenesis. Molecular Neurobiology. 8: 113-20. PMID 7999307 DOI: 10.1007/Bf02780661  0.345
1995 Priola SA, Caughey B, Wehrly K, Chesebro B. A 60-kDa prion protein (PrP) with properties of both the normal and scrapie-associated forms of PrP. The Journal of Biological Chemistry. 270: 3299-305. PMID 7852415 DOI: 10.1074/Jbc.270.7.3299  0.351
Show low-probability matches.